.9 μm (examiner 1), -2.9 ± 18.6 μm (examiner 2), and 10.
5 ± 21.8 μm (examiner 3), respectively
Gao, Xin,
Huang, Yanming,
Wei, Tonghui,
Xue, Jingmin,
Iurii, Filippov,
Yang, Laishou,
Wang, Liying,
Li, Hao,
Mo, Genshen,
Huang, Yuze,
Xie, Haonan,
Wang, Hang,
Lou, Shenghan,
Han, Peng (2025) the ubiquitin-mediated degradation of RIPK3, thereby reducing the sensitivity of CC cells to
5-fluorouracil (
5Erdman, V.V.,
Karimov, D.D.,
Tuktarova, I.A.,
Petintseva, A.A.,
Timasheva, Y.R.,
Nasibullin, T.R. (2025) to 109 years). Mortality risk was higher among carriers of the STK38L Alu-insertion genotype (Ya
5ac2145
appropriate microRNAs (miR-1246, -181c, -330, -345-
5p, -361, -548a-3p, -548b-
5p, -548c-
5p, -571, -588, -659-3p
Korytina, Gulnaz F.,
Markelov, Vitaly A.,
Gibadullin, Irshat A.,
Zulkarneev, Shamil R.,
Nasibullin, Timur R.,
Zulkarneev, Rustem H.,
Avzaletdinov, Arthur M.,
Avdeev, Sergey N.,
Zagidullin, Naufal Sh. (2025) , LINC00342, H19, MALAT1, DNM3OS, MEG3), miRNAs (miR-218-
5p, miR-126-3p, miR-200a-3p, miR-18a-
5p, miR-29a
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Rakhimova, Ellina M.,
Panda-Jonas, Songhomitra,
Tuliakova, Azaliia M.,
Fakhretdinova, Albina A.,
Jonas, Jost B. (2025) (OR: 1.86; 95%CI:1.10, 2.68) and higher prevalence of diabetic retinopathy (OR: 2.97; 95%CI: 1.68,
5Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Iakupova, Ellina M.,
Fakhretdinova, Albina A.,
Gilmanshin, Timur R.,
Panda-Jonas, Songhomitra,
Jonas, Jost B. (2025) . Prevalence of any, early, intermediate and late AMD was 439/932 (47.1%; 95%CI:44.0,50.0), 126/932 (13.
5%; 95